Treatment of Middle Cerebral Artery Aneurysms with Flow-Diverter Stents: A Systematic Review and Meta-Analysis of 1036 Aneurysms
- 3 June 2026
- journal article
- review article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (6) , 1522-1531
Abstract
The role of flow diversion for middle cerebral artery (MCA) aneurysms remains controversial due to frequent involvement of side branches and bifurcations. While outcomes have been reported in cohort studies and case series, the safety and efficacy of this approach remain uncertain. To evaluate angiographic and clinical outcomes following flow diversion for MCA aneurysms. A systematic literature search was performed across databases in accordance with PRISMA guidelines to identify studies reporting on flow-diverter treatment of MCA aneurysms. Studies including ≥3 patients treated with flow-diverter devices and reporting angiographic or clinical outcomes were eligible for inclusion. Thirty-three studies encompassing 1,036 MCA aneurysms met criteria, representing the largest cohort to date. Data on study design, patient and aneurysm characteristics, treatment details, and angiographic and clinical outcomes were extracted. Pooled estimates with 95% confidence intervals (CIs) were calculated using a random-effects model, with subgroup analyses by aneurysm location and device type. The pooled complete or near-complete occlusion rate was 71% at a mean follow-up of 15 months, with no significant differences across MCA segments (66% proximal, 69% bifurcation, 70% distal) or across device types. The overall complication rate was 13%, predominantly thromboembolic, with a 1% procedural mortality. Functional independence (mRS 0-2) was achieved in 90% of patients. Included studies were predominantly retrospective cohort series and case series with heterogeneity in device type, antiplatelet regimens, follow-up duration, and outcome definitions. Publication bias and underreporting of complications cannot be excluded. Flow diversion for MCA aneurysms achieves approximately 71% complete or near-complete occlusion with a 13% complication rate. These findings may support its consideration in carefully selected cases, though the retrospective evidence base warrants cautious interpretation.Keywords
This publication has 49 references indexed in Scilit:
- Pipeline embolization device in treating middle cerebral artery aneurysms: a single-center experience in 69 consecutive patientsNeuroradiology, 2025
- Microsurgical clipping remains a viable option for the treatment of coilable ruptured middle cerebral artery aneurysms in the endovascular eraNeurosurgical Review, 2025
- Safety and efficacy profile of off-label use of the Pipeline Embolization Device: A systematic review and meta-analysisJournal of Stroke and Cerebrovascular Diseases, 2024
- Flow diverter devices in the treatment of complex middle cerebral artery aneurysms when surgical and endovascular treatments are challengingJournal of Stroke and Cerebrovascular Diseases, 2022
- Flow diversion for aneurysms beyond the circle of Willis: A preliminary experienceJournal of Clinical Neuroscience, 2022
- Pipeline embolization of MCA aneurysms in the M2-M4 segment: Dual center study and meta-analysisClinical Neurology and Neurosurgery, 2022
- Treatment of intracranial aneurysms using the new Surpass Evolve flow diverter: Safety outcomes and six-month imaging follow-upJournal Of Neuroradiology, 2022
- Management of Unruptured Saccular Aneurysms of the M1 Segment with Flow DiversionClinical Neuroradiology, 2016
- Flow Diversion in Middle Cerebral Artery Aneurysms: Is It Really an All-Purpose Treatment?World Neurosurgery, 2016
- Flow diversion for complex middle cerebral artery aneurysmsNeuroradiology, 2014